Jonathan Franke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jonathan Franke has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Christian Peter Richard Hackenberger
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
3 shared publications - Jan Vincent Valenzuela Arafiles
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125 Berlin, Germany
3 shared publications - Christian Hertweck
Department of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Leibniz-HKI), Jena, Germany
2 shared publications Christian Leis
Department of Chemical Biology Leibniz‐Forschungsinstitut für Molekulare Pharmakologie (FMP) Robert‐Rössle‐Strasse 10 13125 Berlin Germany
2 shared publications- Evelyn M. Molloy
Dept. of Biomolecular Chemistry Leibniz Institute for Natural Product Research and Infection Biology Jena Germany
2 shared publications Florian Bredy
Deptartment of Biomolecular Chemistry Leibniz Institute of Natural Product Research and Infection Biology, HKI Beutenbergstrasse 11a 07745 Jena Germany
2 shared publications
Latest Publications
- Open Access
Cellular protein delivery through membrane potential driven water pores
Providing immediate access for functional proteins inside living cells would unlock unprecedented control over cellular processes; however, commonly used endocytic delivery suffers from endosomal trapping and degradation. One of the most powerful non-endosomal delivery methods uses cell surface anchored cell penetrating peptide (CPP)-additives that allow proteins to enter cells directly. Nevertheless, the underlying molecular mechanism involved in direct entry via crossing the cell membrane (protein translocation through the cell) and the major driving forces remain controversially discussed. Here, we provide a stepwise molecular picture on how CPP-additives enable uptake of protein cargoes through direct membrane translocation. CPP-additives accumulate on the cell surface in nucleation zones, locally hyperpolarizing the membrane, and induce transient water pores that allow selective CPP-protein entry without compromising membrane integrity. These fundamental mechanistic insights provide a firm basis for rationally optimizing delivery strategies using highly cationic CPPs, ultimately resulting in innovative and smart protein delivery strategies to advance therapeutic protein applications. Abstract Figure:
Open AccessCellular protein delivery through membrane potential driven water pores
Providing immediate access for functional proteins inside living cells would unlock unprecedented control over cellular processes; however, commonly used endocytic delivery suffers from endosomal trapping and degradation. One of the most powerful non-endosomal delivery methods uses cell surface anchored cell penetrating peptide (CPP)-additives that allow proteins to enter cells directly. Nevertheless, the underlying molecular mechanism involved in direct entry via crossing the cell membrane (protein translocation through the cell) and the major driving forces remain controversially discussed. Here, we provide a stepwise molecular picture on how CPP-additives enable uptake of protein cargoes through direct membrane translocation. CPP-additives accumulate on the cell surface in nucleation zones, locally hyperpolarizing the membrane, and induce transient water pores that allow selective CPP-protein entry without compromising membrane integrity. These fundamental mechanistic insights provide a firm basis for rationally optimizing delivery strategies using highly cationic CPPs, ultimately resulting in innovative and smart protein delivery strategies to advance therapeutic protein applications. Abstract Figure:
- Open Access
- 9 July 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (34) , e202506802
Intracellular Delivery of Native Proteins by BioReversible Arginine Modification (BioRAM) on Amino Groups
Protein‐based tools are emerging as innovative solutions to interfere with biological pathways in molecular biology and medicine. They offer advantages over traditional small molecules due to their adaptable structural diversity and their ability to engage previously inaccessible cellular targets. However, most proteins do not penetrate the lipid bilayer of mammalian cells and are therefore restricted to extracellular targets. Despite recent advances, a general method for the delivery of functional proteins into human cells remains a significant challenge. In this study, we present a bioreversible protein modification strategy of amines using short arginine‐containing peptides (termed BioRAM) that enables cytosolic delivery starting from genetically non‐engineered proteins. We optimized the bioconjugation strategy to achieve fast intracellular cleavage and complete recovery of the native protein. In combination with our previously established cell‐penetrating peptide (CPP)‐additive protocol, we show superior delivery of fluorescent protein and functional RNase A into the cytosol, achieving physiological response. Moreover, we are able to demonstrate the excellent performance of BioRAM in the presence of serum, thereby broadening the scope for intracellular applications of functional proteins.
- 9 July 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (34) , e202506802
Open AccessIntracellular Delivery of Native Proteins by BioReversible Arginine Modification (BioRAM) on Amino Groups
Protein‐based tools are emerging as innovative solutions to interfere with biological pathways in molecular biology and medicine. They offer advantages over traditional small molecules due to their adaptable structural diversity and their ability to engage previously inaccessible cellular targets. However, most proteins do not penetrate the lipid bilayer of mammalian cells and are therefore restricted to extracellular targets. Despite recent advances, a general method for the delivery of functional proteins into human cells remains a significant challenge. In this study, we present a bioreversible protein modification strategy of amines using short arginine‐containing peptides (termed BioRAM) that enables cytosolic delivery starting from genetically non‐engineered proteins. We optimized the bioconjugation strategy to achieve fast intracellular cleavage and complete recovery of the native protein. In combination with our previously established cell‐penetrating peptide (CPP)‐additive protocol, we show superior delivery of fluorescent protein and functional RNase A into the cytosol, achieving physiological response. Moreover, we are able to demonstrate the excellent performance of BioRAM in the presence of serum, thereby broadening the scope for intracellular applications of functional proteins.
- Open Access
- 9 July 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (34)
Intrazellulärer Transport nativer Proteine durch Bioreversible Arginin‐Modifikation (BioRAM) primärer Aminogruppen
Zusammenfassung: Proteinbasierte Werkzeuge gewinnen zunehmend an Bedeutung als innovative Ansätze zur gezielten Beeinflussung biologischer Signalwege in der Molekularbiologie und Medizin. Im Vergleich zu klassischen niedermolekularen Wirkstoffen bieten sie Vorteile durch ihre strukturelle Diversität und die Fähigkeit, bislang schwer zugängliche zelluläre Zielstrukturen zu adressieren. Allerdings durchdringen die meisten Proteine die Lipiddoppelschicht von Säugerzellen nicht und sind daher auf extrazelluläre Strukturen beschränkt. Trotz jüngster Fortschritte stellt der intrazelluläre Transport funktioneller Proteine in humane Zellen weiterhin eine erhebliche Herausforderung dar. In der vorliegenden Studie präsentieren wir eine bioreversible Modifikationsstrategie primärer Amine mithilfe kurzer, Arginin‐haltiger Peptide (bezeichnet als BioRAM), welche die zytosolische Aufnahme genetisch nicht veränderter Proteine ermöglicht. Die Biokonjugationsstrategie wurde dahingehend optimiert, eine schnelle intrazelluläre Abspaltung und vollständige Wiederherstellung der nativen Proteinfunktion zu gewährleisten. In Kombination mit unserem zuvor etablierten zellpenetrierenden Peptid‐Additivprotokoll demonstrieren wir einen effizienten intrazellulären Transport von fluoreszierenden Proteinen und funktioneller RNase A, die in der Zelle zu physiologisch relevanten Effekten führen. Darüber hinaus zeigen wir die hohe Leistungsfähigkeit von BioRAM auch in Anwesenheit von Serum, was das Anwendungsspektrum funktioneller Proteine im intrazellulären Kontext deutlich erweitert.
- 9 July 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (34)
Open AccessIntrazellulärer Transport nativer Proteine durch Bioreversible Arginin‐Modifikation (BioRAM) primärer Aminogruppen
Zusammenfassung: Proteinbasierte Werkzeuge gewinnen zunehmend an Bedeutung als innovative Ansätze zur gezielten Beeinflussung biologischer Signalwege in der Molekularbiologie und Medizin. Im Vergleich zu klassischen niedermolekularen Wirkstoffen bieten sie Vorteile durch ihre strukturelle Diversität und die Fähigkeit, bislang schwer zugängliche zelluläre Zielstrukturen zu adressieren. Allerdings durchdringen die meisten Proteine die Lipiddoppelschicht von Säugerzellen nicht und sind daher auf extrazelluläre Strukturen beschränkt. Trotz jüngster Fortschritte stellt der intrazelluläre Transport funktioneller Proteine in humane Zellen weiterhin eine erhebliche Herausforderung dar. In der vorliegenden Studie präsentieren wir eine bioreversible Modifikationsstrategie primärer Amine mithilfe kurzer, Arginin‐haltiger Peptide (bezeichnet als BioRAM), welche die zytosolische Aufnahme genetisch nicht veränderter Proteine ermöglicht. Die Biokonjugationsstrategie wurde dahingehend optimiert, eine schnelle intrazelluläre Abspaltung und vollständige Wiederherstellung der nativen Proteinfunktion zu gewährleisten. In Kombination mit unserem zuvor etablierten zellpenetrierenden Peptid‐Additivprotokoll demonstrieren wir einen effizienten intrazellulären Transport von fluoreszierenden Proteinen und funktioneller RNase A, die in der Zelle zu physiologisch relevanten Effekten führen. Darüber hinaus zeigen wir die hohe Leistungsfähigkeit von BioRAM auch in Anwesenheit von Serum, was das Anwendungsspektrum funktioneller Proteine im intrazellulären Kontext deutlich erweitert.
- Open Access
- 4 July 2022
- Published by Wiley in Angewandte Chemie
- Vol. 134 (32)
Alternative Benzoxazole Assembly Discovered in Anaerobic Bacteria Provides Access to Privileged Heterocyclic Scaffold
Benzoxazole scaffolds feature prominently in diverse synthetic and natural product‐derived pharmaceuticals. Our understanding of their bacterial biosynthesis is, however, limited to ortho‐substituted heterocycles from actinomycetes. We report an overlooked biosynthetic pathway in anaerobic bacteria (typified in Clostridium cavendishii) that expands the benzoxazole chemical space to meta‐substituted heterocycles and heralds a distribution beyond Actinobacteria. The first benzoxazoles from the anaerobic realm (closoxazole A and B) were elucidated by NMR and chemical synthesis. By genome editing in the native producer, heterologous expression in Escherichia coli, and systematic pathway dissection we show that closoxazole biosynthesis invokes an unprecedented precursor usage (3‐amino‐4‐hydroxybenzoate) and manner of assembly. Synthetic utility was demonstrated by the precursor‐directed biosynthesis of a tafamidis analogue. A bioinformatic survey reveals the pervasiveness of related gene clusters in diverse bacterial phyla.
- 4 July 2022
- Published by Wiley in Angewandte Chemie
- Vol. 134 (32)
Open AccessAlternative Benzoxazole Assembly Discovered in Anaerobic Bacteria Provides Access to Privileged Heterocyclic Scaffold
Benzoxazole scaffolds feature prominently in diverse synthetic and natural product‐derived pharmaceuticals. Our understanding of their bacterial biosynthesis is, however, limited to ortho‐substituted heterocycles from actinomycetes. We report an overlooked biosynthetic pathway in anaerobic bacteria (typified in Clostridium cavendishii) that expands the benzoxazole chemical space to meta‐substituted heterocycles and heralds a distribution beyond Actinobacteria. The first benzoxazoles from the anaerobic realm (closoxazole A and B) were elucidated by NMR and chemical synthesis. By genome editing in the native producer, heterologous expression in Escherichia coli, and systematic pathway dissection we show that closoxazole biosynthesis invokes an unprecedented precursor usage (3‐amino‐4‐hydroxybenzoate) and manner of assembly. Synthetic utility was demonstrated by the precursor‐directed biosynthesis of a tafamidis analogue. A bioinformatic survey reveals the pervasiveness of related gene clusters in diverse bacterial phyla.
- Open Access
- 28 June 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (32) , e202205409
Alternative Benzoxazole Assembly Discovered in Anaerobic Bacteria Provides Access to Privileged Heterocyclic Scaffold
Benzoxazole scaffolds feature prominently in diverse synthetic and natural product‐derived pharmaceuticals. Our understanding of their bacterial biosynthesis is, however, limited to ortho‐substituted heterocycles from actinomycetes. We report an overlooked biosynthetic pathway in anaerobic bacteria (typified in Clostridium cavendishii) that expands the benzoxazole chemical space to meta‐substituted heterocycles and heralds a distribution beyond Actinobacteria. The first benzoxazoles from the anaerobic realm (closoxazole A and B) were elucidated by NMR and chemical synthesis. By genome editing in the native producer, heterologous expression in Escherichia coli, and systematic pathway dissection we show that closoxazole biosynthesis invokes an unprecedented precursor usage (3‐amino‐4‐hydroxybenzoate) and manner of assembly. Synthetic utility was demonstrated by the precursor‐directed biosynthesis of a tafamidis analogue. A bioinformatic survey reveals the pervasiveness of related gene clusters in diverse bacterial phyla.
- 28 June 2022
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (32) , e202205409
Open AccessAlternative Benzoxazole Assembly Discovered in Anaerobic Bacteria Provides Access to Privileged Heterocyclic Scaffold
Benzoxazole scaffolds feature prominently in diverse synthetic and natural product‐derived pharmaceuticals. Our understanding of their bacterial biosynthesis is, however, limited to ortho‐substituted heterocycles from actinomycetes. We report an overlooked biosynthetic pathway in anaerobic bacteria (typified in Clostridium cavendishii) that expands the benzoxazole chemical space to meta‐substituted heterocycles and heralds a distribution beyond Actinobacteria. The first benzoxazoles from the anaerobic realm (closoxazole A and B) were elucidated by NMR and chemical synthesis. By genome editing in the native producer, heterologous expression in Escherichia coli, and systematic pathway dissection we show that closoxazole biosynthesis invokes an unprecedented precursor usage (3‐amino‐4‐hydroxybenzoate) and manner of assembly. Synthetic utility was demonstrated by the precursor‐directed biosynthesis of a tafamidis analogue. A bioinformatic survey reveals the pervasiveness of related gene clusters in diverse bacterial phyla.